Drug Profile
Hydroxychloroquine capsule - APT Pharmaceuticals
Latest Information Update: 23 Dec 2021
Price :
$50
*
At a glance
- Originator APT Pharmaceuticals Inc
- Class Antimalarials; Antivirals; Chlorobenzenes; Disease-modifying antirheumatics; Ethanolamines; Quinolines; Small molecules
- Mechanism of Action Phospholipase A2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Ulcerative colitis
Most Recent Events
- 24 Aug 2005 No development reported - Preclinical for Ulcerative colitis in USA (PO)
- 01 Jul 2004 Preclinical trials in Ulcerative colitis in USA (PO)